CS
AMGN icon

Credit Suisse’s Amgen AMGN Stock Holding History

Credit Suisse’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,300
Closed -$22.6M – 3609
2021
Q4 		$22.6M Buy
100,300
+20,900
+26% +$4.41M 0.01% 1026
2021
Q3 		$16.9M Buy
79,400
+4,700
+6% +$1.08M 0.01% 1178
2021
Q2 		$18.2M Sell
74,700
-26,100
-26% -$6.42M 0.01% 1194
2021
Q1 		$25.1M Sell
100,800
-78,800
-44% -$18.8M 0.01% 1043
2020
Q4 		$41.3M Sell
179,600
-50,200
-22% -$11.6M 0.02% 800
2020
Q3 		$58.4M Buy
229,800
+71,800
+45% +$17.8M 0.04% 544
2020
Q2 		$37.3M Sell
158,000
-11,900
-7% -$2.72M 0.03% 661
2020
Q1 		$34.4M Buy
169,900
+29,300
+21% +$6.4M 0.03% 569
2019
Q4 		$33.9M Buy
140,600
+110,700
+370% +$24.4M 0.02% 741
2019
Q3 		$5.79M Sell
29,900
-17,900
-37% -$3.44M ﹤0.01% 1642
2019
Q2 		$8.81M Sell
47,800
-35,000
-42% -$6.27M 0.01% 1393
2019
Q1 		$15.7M Buy
82,800
+38,400
+86% +$7.33M 0.01% 991
2018
Q4 		$8.64M Sell
44,400
-40,400
-48% -$7.88M 0.01% 1232
2018
Q3 		$17.6M Buy
84,800
+25,000
+42% +$4.93M 0.02% 947
2018
Q2 		$11M Sell
59,800
-140,400
-70% -$24.8M 0.01% 1179
2018
Q1 		$34.1M Buy
200,200
+40,200
+25% +$7.38M 0.03% 586
2017
Q4 		$27.8M Sell
160,000
-241,200
-60% -$42.7M 0.02% 701
2017
Q3 		$74.8M Buy
401,200
+156,200
+64% +$27.7M 0.07% 284
2017
Q2 		$42.2M Sell
245,000
-30,600
-11% -$4.98M 0.04% 469
2017
Q1 		$45.2M Buy
275,600
+245,600
+819% +$40.8M 0.04% 461
2016
Q4 		$4.39M Hold
30,000
– – ﹤0.01% 1746
2016
Q3 		$5M Buy
+30,000
New +$5.07M ﹤0.01% 1654
2016
Q1 		– Sell
-40,000
Closed -$6.49M – 3960
2015
Q4 		$6.49M Buy
+40,000
New +$6.29M 0.01% 1401
2015
Q1 		– Sell
-220,000
Closed -$35M – 4350
2014
Q4 		$35M Buy
+220,000
New +$34.3M 0.03% 619

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's AMGN Position: Q1 2024 in Review

Credit Suisse reduced its Amgen (AMGN) stake by 5.1% in Q1 2024, selling an estimated $17.2M and leaving 1,096,086 shares worth $312M. The position accounts for 0.3% of the portfolio, ranked #58.

Credit Suisse first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $690M in Q3 2014. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Credit Suisse held 1,096,086 shares of Amgen worth $312M as of Q1 2024.
  • Credit Suisse sold 58,708 Amgen shares in Q1 2024, an estimated $17.2M.
  • Amgen made up 0.3% of Credit Suisse's portfolio in Q1 2024, its #58 holding.
  • Credit Suisse first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Amgen position peaked at $690M in Q3 2014.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.